Lv71
5000 积分 2022-09-16 加入
Tirzepatide for Metabolic Dysfunction– Associated Steatohepatitis with Liver Fibrosis
21天前
已完结
Musculoskeletal adverse events with incretin-based diabetes drugs: a FAERS pharmacovigilance study
1个月前
已完结
Male sexual dysfunction associated with GLP-1 receptor agonists: a cross-sectional analysis of FAERS data
3个月前
已完结
Rhabdomyolysis triggered by initiation of tirzepatide
3个月前
已完结
Tirzepatide associated autoimmune encephalitis: A case report
3个月前
已完结
Diabetic lumbosacral radiculoplexus neuropathy after glucagon-like peptide 1 receptor agonist use: A case series
3个月前
已完结
Disproportionality analysis on semaglutide and nonarteritic anterior ischemic optic neuropathy in the FDA adverse event reporting system: An emerging pharmacovigilance signal?
3个月前
已关闭
Semaglutide-induced Wernicke encephalopathy: a comprehensive analysis
3个月前
已完结
Efficacy and Safety of Once-Weekly Semaglutide Versus Exenatide ER in Subjects With Type 2 Diabetes(SUSTAIN 3):A 56-Week，Open-Label，Randomized Clinical Trial
4个月前
已完结
Semaglutide versus dulaglutide once weekly in patients with type 2 diabetes(SUSTAIN 7):a randomised，open-label，phase 3b trial
4个月前
已完结
皖公网安备34019202002308
